About Excel Biolife Private Limited
Data last updated:
Excel Biolife Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 February 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U67120MH2000PTC124165. Its GSTIN is 27AAFCS0122D1ZY (Maharashtra).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹11.3 Lakh. It was formerly known as Sensex Services Private Limited. It is led by directors Rajendra Dahyabhai Patel and Shivkumar Radhemohan Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹57.71 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.38 Cr (net margin 2.4%) and EBITDA of ₹2.02 Cr (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 100% over five years.
The company is associated with 1 brand: Excel Biolife. As per MCA filings, the company has satisfied charges of ₹17.5 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website excelbiolife.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressShop No. 3 The Gorai Indraprastha Chsl Rsc – 37 Gillary Gunj Plot No – 90 Gorai – 2 Boriv, Ali (W), Mumbai, Maharashtra, India – 400092
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Excel Biolife Private Limited
The main business activity of Excel Biolife is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Excel Biolife Private Limited FY 2024 filings available
Excel Biolife Private Limited reported revenue of ₹57.71 Cr (up 4% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Excel Biolife Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 100% over five years, including 4% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Excel Biolife Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.02 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.38 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Excel Biolife Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Excel Biolife are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Excel Biolife Private Limited
Excel Biolife Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ocean Healthcare Private Limited | ₹58.49 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Egmore Nungambakkm, Tamil Nadu, India |
| Unimarck Pharma (India) Limited | ₹58.24 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Chandigarh, India |
| Livealth Biopharma Private Limited | ₹58.19 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| Uma Ayurvedics Private Limited | ₹58.01 Cr (FY 2024) | •••• | •••• | 61.0% | •••• | Uttar Pradesh, India |
| Stedman Pharmaceuticals Private Limited | ₹57.77 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Chennai, Tamil Nadu, India |
| Excel Biolife Private Limited this company | ₹57.71 Cr (FY 2023) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| And Healthcare Limited | ₹57.48 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | Mohali, Punjab, India |
| Alna Biotech Private Limited | ₹57.47 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Chandigarh, India |
| Accretion Pharmaceuticals Limited | ₹57.47 Cr (FY 2025) | •••• | •••• | 329.0% | •••• | Sanand, Gujarat, India |
| VPL Chemicals Private Limited | ₹57.32 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Bangalore, Karnataka, India |
| Alidac Pharmaceuticals Limited | ₹57.16 Cr (FY 2019) | •••• | •••• | -60.0% | •••• | Matoda, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Excel Biolife by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Excel Biolife Private Limited
Excel Biolife Private Limited is audited by VALERA SHAH & ASSOCIATES LLP for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VALERA SHAH & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Excel Biolife Private Limited
Excel Biolife has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Dahyabhai Patel | Director | 25 Apr 2018 | 8 Years 5 Months | Current |
| Shivkumar Radhemohan Tiwari | Director | 24 Oct 2024 | 1 Years 11 Months | Current |
Ownership and Shareholding of Excel Biolife Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Excel Biolife Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jul 2015 | Others | ₹1 Cr | Satisfied |
| 21 Jan 2015 | Others | ₹6.25 Cr | Satisfied |
| 08 Jan 2015 | Others | ₹5.25 Cr | Satisfied |
| 12 Feb 2014 | Bank of Baroda | ₹1 Cr | Satisfied |
| 23 Mar 2011 | Bank of Baroda | ₹4 Cr | Satisfied |
Total charge records: 5 View all charges
Legal Cases of Excel Biolife Private Limited
Excel Biolife Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 02 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Company petition | Filed against the company by Vidhya Pharmachem Private Limited | Disposed |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Serum Institute of India Private Limited | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Excel Biolife Private Limited
Excel Biolife operates one associated brand: Excel Biolife. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution in India with a focus on quality therapeutics. | excelbiolife.com |
Employees and EPFO Compliance at Excel Biolife Private Limited
Employment history and EPFO contributions of people linked to Excel Biolife.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Excel Biolife Private Limited
Excel Biolife Private Limited has 6 board changes on record since 2011: 2 appointments and 4 cessations. The latest: Shivkumar Radhemohan Tiwari was appointed as Director on 24 Oct 2024.
11 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Excel Biolife Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Excel Biolife Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Excel Biolife Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Excel Biolife Private Limited
Excel Biolife has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCS0122D1ZY | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Excel Biolife Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Excel Biolife Private Limited
Excel Biolife is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 February 2000 (26+ years old) and is registered under CIN U67120MH2000PTC124165.
Excel Biolife reported revenue of ₹57.71 Cr for FY 2023 (up 4% YoY).
Excel Biolife has 2 current directors:
- Rajendra Dahyabhai Patel - Director
- Shivkumar Radhemohan Tiwari - Director
Excel Biolife reported a net profit of ₹1.38 Cr (net margin 2.4%) and EBITDA of ₹2.02 Cr (EBITDA margin 3.5%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Excel Biolife is 43% over three years and 100% over five years. In the latest year (FY 2023) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Excel Biolife is 27AAFCS0122D1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Excel Biolife is U67120MH2000PTC124165. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Excel Biolife has 2 court cases on record: 2 filed against it. Most are in the high courts.
Excel Biolife was incorporated on 11 February 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Excel Biolife by revenue are Ocean Healthcare Private Limited, Unimarck Pharma (India) Limited, Livealth Biopharma Private Limited, Uma Ayurvedics Private Limited, Stedman Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Shivkumar Radhemohan Tiwari was appointed as Director on 24 Oct 2024. Rajendra Dahyabhai Patel ceased to be Additional Director on 04 Apr 2019. Rajendra Dahyabhai Patel was appointed as Director on 25 Apr 2018. Excel Biolife has 6 board changes on record in total.